TIDMODX

RNS Number : 9918L

Omega Diagnostics Group PLC

24 April 2018

Omega Diagnostics Group PLC

("Omega" or the "Company")

PDMR Dealing

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that it was notified on 24 April 2018 that Edward Valente, Group R&D Director of the Company has purchased 124,044 ordinary shares of 4 pence each in the capital of the Company ("Ordinary Shares") at a price of 14.5 pence per Ordinary Share.

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

 
1)  Details of Persons Discharging Managerial 
     Responsibilities "PDMR" / person closely 
     associated with them ('PCA') 
a)  Name                  Edward Valente 
2.  Reason for notification 
b)  Position /            Group R&D Director 
     status 
c)  Initial notification  Initial Notification 
     / amendment 
3.  Details of the issuer, emission allowance 
     market participant, auction platform, auctioneer 
     or auction monitor 
b)  Name                  Omega Diagnostics Group plc 
c)  LEI                   2138007U9P4BTZTYIR92 
4.  Details of the transaction(s): section 
     to be repeated for (i) each type of instrument; 
     (ii) each type of transaction; (iii) each 
     date; and (iv) each place where transactions 
     have been conducted 
a)  Description           Purchase of Ordinary Shares 
     of the financial      GB00B1VCP282 
     instrument 
     Identification 
     code 
b)  Nature of             Purchase of Ordinary Shares 
     the transaction 
c)  Price(s) and           Volume(s)  Price(s) GBP 
     volume(s)              124,044    0.145 
d)  Aggregated            Aggregate Volume(s)  Volume weighted 
     information                                 average Price) 
     Aggregated                                  GBP 
     volume Price          124,044              0.145 
e)  Date of the           24/04/18 
     transaction 
f)  Place of the          LSE 
     transaction

Contacts:

 
 Omega Diagnostics Group                               Tel: 01259 763 030 
  PLC 
 Colin King, Chief Executive                     www.omegadiagnostics.com 
 Kieron Harbinson, Group 
  Finance Director 
 Jag Grewal, Group Sales 
  and Marketing Director 
 
 finnCap Ltd                                           Tel: 020 7220 0500 
 Geoff Nash/James Thompson 
  (Corporate Finance) 
 Camille Gochez (Corporate 
  Broking) 
 
 Walbrook PR Limited           Tel: 020 7933 8780 or omega@walbrookpr.com 
 Paul McManus                                          Mob: 07980 541 893 
 Lianne Cawthorne                                      Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHFKQDKABKDBQB

(END) Dow Jones Newswires

April 24, 2018 12:04 ET (16:04 GMT)

Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Omega Diagnostics Charts.
Omega Diagnostics (LSE:ODX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Omega Diagnostics Charts.